ÐÓ°ÉÔ­´´

Connecta Therapeutics, based in Barcelona, is emerging as a key player in health technology with a focus on treating central nervous system disorders. By developing solutions for conditions inadequately addressed by current pharmaceuticals or therapies, the company meets a significant market need. Their B2B model, targeting healthcare providers and pharmaceutical companies, suggests steady revenue streams. Backed by the Prous Institute for Biomedical Research and Spain's Ministry of Science and Innovation, Connecta Therapeutics has financial support and credibility. Given the limitations of existing treatments, their specialized approach promises substantial impact and business growth.